ReviewJournal of ophthalmology2017
Rho-Kinase/ROCK as a Potential Drug Target for Vitreoretinal Diseases.
Muneo Yamaguchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it
ReviewJournal of ophthalmology2017
Muneo Yamaguchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.